NCT00354770View on ClinicalTrials.gov

N-Acetyl Cysteine in Trichotillomania

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Trichotillomania
Interventions
DRUG

Placebo

daily

DRUG

N-Acetyl Cysteine

600mg capsules in varying doses for 12 weeks.

Trial Locations (1)

60637

University of Chicago Medical Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT00354770 - N-Acetyl Cysteine in Trichotillomania | Biotech Hunter | Biotech Hunter